Coeur MiningNYSE: CDE

ROCKVILLE, Md. and SUZHOU, China , Nov. 17, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that a New Drug Application (NDA) for its inhouse developed investigational novel Bcl-2 selective inhibitor, lisaftoclax (APG-2575), for the treatment of patients with relapsed or refractory (r/r) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has been accepted and recommended the Priority Review designation by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA).

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Coeur Mining, Inc. ( NYSE : CDE ), relating to the proposed merger with SilverCrest Metals Inc. Under the terms of the agreement, holders of SilverCrest Common Shares will receive 1.6022 shares of Coeur Common Stock in exchange for each share held. Upon completion of the Arrangement, existing Coeur stockholders will own approximately 63% of outstanding Coeur Common Stock and existing SilverCrest shareholders will own approximately 37% on a fully diluted basis.

Coeur Mining, Inc. (NYSE:CDE ) Q3 2024 Earnings Conference Call November 7, 2024 11:00 AM ET Company Participants Mitchell Krebs - Chairman, President and Chief Executive Officer Michael Routledge - Senior Vice President and Chief Operating Officer Thomas Whelan - Senior Vice President and Chief Financial Officer Conference Call Participants Joseph Reagor - ROTH Capital Partners Operator Good day, and welcome to the Coeur Mining Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.

Coeur Mining (CDE) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.05 per share a year ago.

Does Coeur Mining (CDE) have what it takes to be a top stock pick for momentum investors? Let's find out.

CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today announced that it will report its third quarter 2024 operational and financial results after the New York Stock Exchange closes for trading on Wednesday, November 6, 2024. The Company will be hosting a conference call at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) on Thursday, November 7, 2024. Hosting the call will be Mitchell J. Krebs, Chairman, President and Chief Executive Officer of Coeur, who w.

Coeur signs a deal to acquire all issued and outstanding shares of SilverCrest.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Coeur Mining, Inc. (NYSE: CDE) and SilverCrest Metals Inc. is fair to Coeur shareholders. Halper Sadeh encourages Coeur shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Coeur and its board violated the federal.

Coeur Mining announced Friday an agreement in which the gold and silver miner is using its stock, that has more than doubled this year, to buy SilverCrest Metals in a deal valued at $1.7 billion.